Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 184

1.

Low 25-hydroxyvitamin D levels in people with a solid tumor cancer diagnosis: the tip of the iceberg?

Hauser K, Walsh D, Shrotriya S, Karafa M.

Support Care Cancer. 2014 Jul;22(7):1931-9. doi: 10.1007/s00520-014-2154-y. Epub 2014 Feb 28.

PMID:
24682592
2.

Impact of oral vitamin D supplementation on serum 25-hydroxyvitamin D levels in oncology.

Vashi PG, Trukova K, Lammersfeld CA, Braun DP, Gupta D.

Nutr J. 2010 Nov 23;9:60. doi: 10.1186/1475-2891-9-60.

3.

Serum 25-hydroxyvitamin D is inversely associated with body mass index in cancer.

Vashi PG, Lammersfeld CA, Braun DP, Gupta D.

Nutr J. 2011 May 16;10:51. doi: 10.1186/1475-2891-10-51.

4.

Prevalence and predictors of vitamin D deficiency in healthy adults.

Mitchell DM, Henao MP, Finkelstein JS, Burnett-Bowie SA.

Endocr Pract. 2012 Nov-Dec;18(6):914-23. doi: 10.4158/EP12072.OR.

5.

Vitamin D status in patients with stage IV colorectal cancer: findings from Intergroup trial N9741.

Ng K, Sargent DJ, Goldberg RM, Meyerhardt JA, Green EM, Pitot HC, Hollis BW, Pollak MN, Fuchs CS.

J Clin Oncol. 2011 Apr 20;29(12):1599-606. doi: 10.1200/JCO.2010.31.7255. Epub 2011 Mar 21.

6.

Vitamin D insufficiency in a multiethnic cohort of breast cancer survivors.

Neuhouser ML, Sorensen B, Hollis BW, Ambs A, Ulrich CM, McTiernan A, Bernstein L, Wayne S, Gilliland F, Baumgartner K, Baumgartner R, Ballard-Barbash R.

Am J Clin Nutr. 2008 Jul;88(1):133-9.

7.

Low 25-hydroxyvitamin D levels and cognitive impairment in hemodialysis patients.

Shaffi K, Tighiouart H, Scott T, Lou K, Drew D, Weiner D, Sarnak M.

Clin J Am Soc Nephrol. 2013 Jun;8(6):979-86. doi: 10.2215/CJN.10651012. Epub 2013 Feb 28.

8.

Low 25-hydroxyvitamin D level is independently associated with non-alcoholic fatty liver disease.

Jablonski KL, Jovanovich A, Holmen J, Targher G, McFann K, Kendrick J, Chonchol M.

Nutr Metab Cardiovasc Dis. 2013 Aug;23(8):792-8. doi: 10.1016/j.numecd.2012.12.006. Epub 2013 Feb 13.

9.

Serum concentrations of 25-hydroxyvitamin D and immunoglobulins in an older Swiss cohort: results of the Senior Labor Study.

Sakem B, Nock C, Stanga Z, Medina P, Nydegger UE, Risch M, Risch L.

BMC Med. 2013 Aug 1;11:176. doi: 10.1186/1741-7015-11-176.

10.

Vitamin D status and predictors of hypovitaminosis D in Italian children and adolescents: a cross-sectional study.

Vierucci F, Del Pistoia M, Fanos M, Gori M, Carlone G, Erba P, Massimetti G, Federico G, Saggese G.

Eur J Pediatr. 2013 Dec;172(12):1607-17.

PMID:
23959324
11.

[Vitamin D deficiency in a Spanish cohort of patients with chronic kidney disease].

Yuste C, García De Vinuesa S, Goicoechea M, Barraca D, Panizo N, Quiroga B, Luño J.

Med Clin (Barc). 2013 Oct 19;141(8):338-42. doi: 10.1016/j.medcli.2012.07.026. Epub 2012 Nov 23. Spanish.

PMID:
23182534
12.

Preliminary report: vitamin D deficiency in advanced cancer patients with symptoms of fatigue or anorexia.

Dev R, Del Fabbro E, Schwartz GG, Hui D, Palla SL, Gutierrez N, Bruera E.

Oncologist. 2011;16(11):1637-41. doi: 10.1634/theoncologist.2011-0151. Epub 2011 Sep 30.

13.

Hypovitaminosis D in obese children and adolescents: relationship with adiposity, insulin sensitivity, ethnicity, and season.

Alemzadeh R, Kichler J, Babar G, Calhoun M.

Metabolism. 2008 Feb;57(2):183-91. doi: 10.1016/j.metabol.2007.08.023.

PMID:
18191047
14.

A descriptive study on vitamin D levels in individuals with spinal cord injury in an acute inpatient rehabilitation setting.

Nemunaitis GA, Mejia M, Nagy JA, Johnson T, Chae J, Roach MJ.

PM R. 2010 Mar;2(3):202-8; quiz 228. doi: 10.1016/j.pmrj.2010.01.010.

PMID:
20359685
15.

Vitamin D status in children with cystic fibrosis. Associations with inflammation and bacterial colonization.

Simoneau T, Bazzaz O, Sawicki GS, Gordon C.

Ann Am Thorac Soc. 2014 Feb;11(2):205-10. doi: 10.1513/AnnalsATS.201306-171BC.

PMID:
24423241
16.

Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients.

Blair D, Byham-Gray L, Lewis E, McCaffrey S.

J Ren Nutr. 2008 Jul;18(4):375-82. doi: 10.1053/j.jrn.2008.04.008. Erratum in: J Ren Nutr. 2009 Mar;19(2):195.

PMID:
18558303
17.
18.

25-Hydroxyvitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance).

Van Loon K, Owzar K, Jiang C, Kindler HL, Mulcahy MF, Niedzwiecki D, O'Reilly EM, Fuchs C, Innocenti F, Venook AP; Alliance for Clinical Trials in Oncology.

J Natl Cancer Inst. 2014 Aug 6;106(8). pii: dju185. doi: 10.1093/jnci/dju185. Print 2014 Aug.

19.

Low 25-hydroxyvitamin D levels and mortality in non-dialysis-dependent CKD.

Navaneethan SD, Schold JD, Arrigain S, Jolly SE, Jain A, Schreiber MJ Jr, Simon JF, Srinivas TR, Nally JV Jr.

Am J Kidney Dis. 2011 Oct;58(4):536-43. doi: 10.1053/j.ajkd.2011.04.028. Epub 2011 Aug 4.

20.

Marked 25-hydroxyvitamin D deficiency is associated with poor prognosis in patients with alcoholic liver disease.

Trépo E, Ouziel R, Pradat P, Momozawa Y, Quertinmont E, Gervy C, Gustot T, Degré D, Vercruysse V, Deltenre P, Verset L, Gulbis B, Franchimont D, Devière J, Lemmers A, Moreno C.

J Hepatol. 2013 Aug;59(2):344-50. doi: 10.1016/j.jhep.2013.03.024. Epub 2013 Apr 1.

PMID:
23557869
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk